In patients with pre-existing CAD, copeptin significantly improves the diagnostic accuracy if used in addition to cTnT, but only trended to superiority compared with hs-cTnT alone.
Copeptin provides independent prognostic information, largely by overcoming the challenging interpretation of mild increases in hs-cTnT. CLINICAL TRIAL REGISTRATION
NUMBER:
ClinicalTrials Gov number NCT00470587.
2012-03-16
Eng.
Heart (British Cardiac Society)
Department of Cardiology, University Hospital Basel, Basel, Switzerland.
Heart. 2012 Apr;98(7):558-65
© Galenicom 1999-2013